Epstein Files Search

EFTA01572493Set 10

2012-06-0134p4,273w

Cost Sale High Cost Sale High Cost Sale High Cost Sale EFTA01572513 High Cost ABBOTT LABORATORIES @ 62.7109 940.66 BROKERAGE 0.30 TAX &/OR SEC .02 CREDIT SUISSE FIRST BOSTON ... ABBOTT LABORATORIES @ 62.7358 1,505.66 BROKERAGE 0.48 TAX &/OR SEC .03 DEUTSCHE BANC ALEX BROWN INC (ID: 002824-10-0) ABBOTT LABORATORIES @ 62.645 250.58 BROKERAGE ... LIQUIDNET INC (ID: 002824-10-0) ABBOTT LABORATORIES @ 62.5761 1,314.10 BROKERAGE 0.42 TAX &/OR SEC .03 CREDIT SUISSE FIRST BOSTON LLC (ID: 002824-10-0) ABBOTT LABORATORIES

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01572493.pdf

EFTA01522226Set 10

2012-06-301p257w

Date Selection Method Description Quantity Amount Proceeds Tax Cost Gain/Loss Settled Sales/Maturities/Redemptlons 6/20 Sale ABBOTT LABORATORIES 1 62.7109 940.66 BROKERAGE (15.000) 62.689 940.34 (741.11) 199.23 S 6/25 High Cost ... 8/OR SEC .02 CREDIT SUISSE FIRST BOSTON LLC (ID: 002824-10-0) 6.20 Sale ABBOTT LABORATORIES 1 62.7358 1,505.66 (24.000) 62.715 1.505.15 (1,185.14) 320.01 S 6125 High Cost ... 8/OR SEC .03 DEUTSCHE BANC ALEX BROWN INC (ID: 00282410-0) 6/20 Sale ABBOTT LABORATORIES e 62.645 250.58 BROKERAGE (4.000) 62623 250.49 (197.52) 52.97 S 6/25 High Cost

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01522226.pdf

EFTA00198408Set 9

2002-09-03178p37,272w

COMMISSION 42,00 SEC FEE ,62 AS OF 06/26/02 07/02/02 06/27/02 BOUGHT ABBOTT LABORATORIES ABT 2.700 38.80720 104.983.44 SEE NOTE S ON BACK EXECUTION BY LEHM ... COMMISSION 203,00 SEC FEE 1.03 AS OF 07/01/02 07/08/02 07/02/02 SOLD ABBOTT LABORATORIES AST -1.400 37.37400 52.212.02 SEE NOTE '5* ON BACK EXECUTION BY MLCO ... 07/10/02 JOURNAL AMERICAN EAGLE OUTFITTERS INC AEOS -4.500 NEW TO: J 07/10/02 JOURNAL ABBOTT LABORATORIES ABT -1.300 TO: J 07/10/02 JOURNAL AN ADI -1.300 TO: ■ JRL 07/10/02 JOURNAL BE BEAS

https://www.justice.gov/epstein/files/DataSet%209/EFTA00198408.pdf

EFTA01322382Set 10

2002-05-28178p39,968w

COMMISSION 42.00 SEC FEE .62 AS OF 06/28/02 VSEESEOCIN9- ANGS 07/02/02 06/27/02 SOUGHT ABBOTT LABORATORIES ABT 2.700 38.80720 104,983.44 SEE NOTE 5' ON BAD( EXECUMN BY LOIM ... JOURNAL • OIL • AMERICAN EAGLE OUTFITTERS INC AEOS 4.500 MEW 70: Ii99/055-08526-1450 • Mt • 07/10102 JOURNAL ABBOTT LABORATORIES ABE 4.303 70: 99W055-0852644S0 r 07110102 JOURNAL • AL • ANALOG DEVICES

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01322382.pdf

EFTA01260851Set 9

2003-06-1892p16,871w

remmencw DtSCRPnOli SYYSOUGUSIP 011.11111T MCI tar, ma3W11 OISDIT ' ,WW1 38105/02 07)31/02 SOLD ABBOTT LABORATORIES AM -1,300 41.08000 63.324.39 0 UNSOLICITED SEE NOTE 5 ON BACK • 0 08/05102 ... CRBARO INC BCR 1.700 0.2200 374.00 REC 07/2202 PAY 08.02102 08115(02 ABBOTT LABORATORIES ABT 1.300 0.2350 305.50 REC ON15/02 PAY Den sox r 06/15/02 NOYACHEMICALS CORP REC 07/31102

https://www.justice.gov/epstein/files/DataSet%209/EFTA01260851.pdf

EFTA01572182Set 10

2011-08-0130p3,052w

Gain/Loss Estimated Annual Income Accrued Dividends Yield Equity Detail Price US Large Cap Equity ABBOTT LABORATORIES AIR PRODUCTS & CHEMICALS INC AUTOMATIC DATA PROCESSING ... Purchase Purchase Purchase Purchase Purchase Purchase Purchase Purchase Purchase Description ABBOTT LABORATORIES @ 49.3607 7,157.30 BROKERAGE 2.90 CITATION GROUP/BCC CLRG (ID: 002824-10-0) GENERAL MILLS ... KELLOGG CO @ 52.43 157.29 BROKERAGE 0.06 INVESTMENT TECHNOLOGY GROUP (ITG) (ID: 487836-10-8) ABBOTT LABORATORIES @ 49.4941 148.48 BROKERAGE 0.06 INVESTMENT TECHNOLOGY GROUP

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01572182.pdf

EFTA00197957Set 9

2002-12-3191p15,663w

DATE DATE TRANSACTION DESORPTION SYMI3WOUSP GUMMY PRICE DEBIT AMOUNT CREPT AMUNT oatosio2 07/31/02 SOLD ABBOTT LABORATORIES ABT -1,300 41.08000 53,324.39 UNSOLICITED SEE NOTE 5 ON BACK bitbstb 67/i1/6 ... BARD INC SCR 1.700 0.2200 374.00 REC 07/22/02 PAY 08/02(02 ce/15/02 ABBOTT LABORATORIES ABT 1.300 0.2350 305.50 REC 07/15102 PAY 08/15.02 08/15/02 NOVA CHEMICALS CORP

https://www.justice.gov/epstein/files/DataSet%209/EFTA00197957.pdf

EFTA01572352Set 10

2012-02-0132p4,155w

Concentrated & Other Equity ABBOTT LABORATORIES PEOPLE'S UNITED FINANCIAL INC Total Concentrated & Other Equity 002824-10-0 ABT 12.59 712704-10-5 PBCT ... 02/01/12 RAYTHEON CO @ 0.43 PER SHARE (ID: 755111-50-7) ABBOTT LABORATORIES @ 0.48 PER SHARE (ID: 002824-10-0) PROCTER & GAMBLE CO @ 0.525 PER SHARE (ID: 742718-10-9) COLGATE

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01572352.pdf

EFTA01572256Set 10

2011-11-0131p4,076w

position adjusted for Pending Trade Activity. Equity Detail Price US Large Cap Equity P ABBOTT LABORATORIES AIR PRODUCTS & CHEMICALS INC 002824-10-0 ABT 83.75 009158-10-6 APD Page ... PRODUCTS & CHEMICALS INC @ 0.58 PER SHARE (ID: 009158-10-6) ABBOTT LABORATORIES @ 0.48 PER SHARE (ID: 002824-10-0) PROCTER & GAMBLE CO @ 0.525 PER SHARE (ID: 742718-10-9) COLGATE

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01572256.pdf

EFTA01572448Set 10

2012-05-0145p5,416w

Gain/Loss Estimated Annual Income Accrued Dividends Yield Equity Detail Price US Large Cap Equity ABBOTT LABORATORIES ANALOG DEVICES INC 002824-10-0 ABT 36.37 032654-10-5 ADI AUTOMATIC DATA ... 05/01/12 RAYTHEON CO @ 0.50 PER SHARE (ID: 755111-50-7) ABBOTT LABORATORIES @ 0.51 PER SHARE (ID: 002824-10-0) COLGATE PALMOLIVE CO @ 0.62 PER SHARE (ID: 194162-10-3) PROCTER

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01572448.pdf

EFTA01141522Set 9

2013-11-1033p13,378w

Having worked for health care giants including Johnson & Johnson, Syntex Labs, Bristol-Myers Squibb, Abbott Laboratories and Forest Laboratories. Gwen offers an insider's knowledge of dangers from the pharmaceutical

https://www.justice.gov/epstein/files/DataSet%209/EFTA01141522.pdf

EFTA00149214Set 9

2020-08-2840p23,666w

From: To: Subject: [EXTERNAL EMAIL] - FBI Public Affairs News Briefing Friday, August 28, 2020 Date

https://www.justice.gov/epstein/files/DataSet%209/EFTA00149214.pdf

EFTA01572384Set 10

2012-03-0128p3,791w

Gain/Loss Estimated Annual Income Accrued Dividends Yield Equity Detail Price US Large Cap Equity ABBOTT LABORATORIES ANALOG DEVICES INC 002824-10-0 ABT 40.40 032654-10-5 ADI AUTOMATIC DATA

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01572384.pdf

EFTA01522103Set 10

2011-11-011p162w

Price Gummy Value Original Cost Gain/Loss Accrued Div. Yield US Large Cap Equity ABBOTT LABORATORIES 54.55 146.000 8,073.40 7,30874 784.66 284.16 3.52% 002824-10-OAST P AIR PRODUCTS

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01522103.pdf

EFTA01522227Set 10

2012-06-011p222w

Date Selection Method Description Quantity Amount Proceeds Tax Cost GaIn/Loss Settled Sales/Maturities/Redemptions 6/22 Sale ABBOTT LABORATORIES @ 62.32 4,113.12 BROKERAGE (66.000) 62.299 4,111.71 (3,259.13) 852.58 S 6/27 High

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01522227.pdf

EFTA01572235Set 10

2011-12-0121p2,261w

Gain/Loss Estimated Annual Income Accrued Dividends Yield Equity Detail Price US Large Cap Equity ABBOTT LABORATORIES AIR PRODUCTS & CHEMICALS INC AUTOMATIC DATA PROCESSING

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01572235.pdf

EFTA01522138Set 10

2012-01-311p163w

Price Quantity Value Original Cost Gain.toss Accrued Div. Yield US Large Cap Equity ABBOTT LABORATORIES 54.15 148.000 8,014.20 7,308.74 705.48 284.16 3.55% 002824-10-0 AST 71.04 ANALOG

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01522138.pdf

EFTA01522122Set 10

2011-12-311p144w

Price Quantity Value Original Cost Gain/Loss Accrued Div. Yield US Large Cap Equity ABBOTT LABORATORIES 56.23 148.000 8,322.04 7,308.74 1,013.30 284.16 3.41% 002824-10-0 ABT ANALOG

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01522122.pdf

EFTA01902735Set 10

2013-03-055p1,672w

EFTA_R1_00333099 EFTA01902737 billionaire after selling Kos Pharmaceuticals Inc. in 2006 to Abbott Laboratories for $3.7 billion. "I knew what it took to get a drug approved

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01902735.pdf

EFTA02295528Set 11

49p3,041w

Prior to joining SmithKline Beecham plc Mr. Pien worked for six years at Abbott Laboratories and for five years at Merck & Co. Mr. Pien is also a director of Vanda

https://www.justice.gov/epstein/files/DataSet%2011/EFTA02295528.pdf